📰 Psycheceutical Bioscience News
Page 2 - Psycheceutical Bioscience News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Psycheceutical Bioscience. Real-time updates on events, politics, business and more.
March 29, 2023
Doblin commented on the potential of the company’s NeuroDirect™ ketamine topical cream to help those suffering from PTSD...
March 29, 2023
Doblin commented on the potential of the company’s NeuroDirect™ ketamine topical cream to help those suffering from PTSD Psycheceutical Chief Visionary Officer Zappy Zapolin and CEO Chad... | March 29, 2023
January 26, 2023
Topical ketamine formulations could improve the methods of treating post-traumatic stress disorder (PTSD)...
January 11, 2023
Psycheceutical Announces Julian Bailes, M.D. as Board Member and Chief Medical Officer - read this article along with other careers information, tips and advice on BioSpace
January 10, 2023
Renowned neurosurgeon to oversee the development of breakthrough psychedelic therapeutics...
October 4, 2022
Chief Visionary Officer of Psycheceutical, Zappy Zapolin, will join other prominent leaders in Psychedelics on Benzinga’s Council Board...
August 16, 2022
Vici Health Sciences CEO Anish Dhanarajan to join Psycheceutical as Research and Development Advisor...
May 10, 2022
The psychedelics industry is quickly becoming the latest playground for celebrity investors and influencers in the financial sphere. Kevin Harrin...
March 29, 2022
Zapolin Set to Outline the Lucrative Financial Potential of Psychedelic Medicine